DOST identifies 18 sites of clinical trials for 3 vaccines | Inquirer News
Close  
MMDA EYES ISOLATION FACILITY AS VACCINATION CENTER

DOST identifies 18 sites of clinical trials for 3 vaccines

/ 05:18 AM January 23, 2021

MANILA, Philippines — The Department of Science and Technology (DOST) announced on Friday that the clinical trials for three COVID-19 vaccines will be held in 18 facilities in Metro Manila, Laguna and Cavite provinces, as well as the cities of Bacolod and Iloilo in Western Visayas.

Rowena Guevara, Undersecretary for Research and Development of the DOST, said at an online press briefing that the late stage clinical trials would be conducted by Janssen Pharmaceutica, Clover Biopharmaceuticals and Sinovac Biotech.

ADVERTISEMENT

Janssen Pharmaceutica, the drug subsidiary of American conglomerate Johnson & Johnson that developed vaccine candidate JNJ-78436735, will conduct their trials in Makati City, San Pablo and Cabuyao in Laguna, Iloilo City and Bacolod City.

Clover Biopharmaceuticals Australia, the Australian subsidiary of Sichuan Clover Biopharmaceuticals of China, which developed the S-Trimer vaccine, or SCB-2019, will hold its trials in Quezon City, Makati City, Manila, Taguig City, Las Piñas City, Muntinlupa City in Metro Manila, as well as Calamba in Laguna and Dasmariñas in Cavite.

FEATURED STORIES

The Beijing-based Sinovac Biotech, which developed the vaccine candidate CoronaVac, will hold its trials in Quezon City, Marikina City, Pasay City in Metro Manila and Alaminos in Laguna.

Guevarra said while there was still no definite date when the trials would start, “they intend to start the soonest.”

The Food and Drug Administration approved the Phase 3 clinical trial application of Janssen’s COVID-19 vaccine on Dec. 29, 2020, while Chinese firm Clover received its approval on Jan. 8. Sinovac’s application was approved earlier this week.

The Metropolitan Manila Development Authority (MMDA) is planning to turn the agency’s 800-square-meter quarantine facility in Makati City into a national vaccination center to help the government in its vaccination program.

“The MMDA quarantine facility is open for any national government agency that needs a place to efficiently roll out the antiCOVID-19 vaccination program,” MMDA chair Benhur Abalos said in a statement on Friday.

The MMDA’s isolation facility was built on May as a temporary holding area for its own employees who had to undergo the mandatory 14-day quarantine prescribed by the Department of Health. The facility is air-conditioned, has shower rooms, comfort rooms and lavatories and Wi-Fi connection.

During his first day in office, Abalos said helping the government in its pandemic response would remain one of the priorities of the MMDA and that the agency would assist local chief executives in their vaccine logistics for or quick mobility across the National Capital Region. —WITH A REPORT FROM MARIEJO S. RAMOS

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: clinical trials, coronavirus Philippines, coronavirus vaccines, COVID-19, DOST
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.